84 results
P
severe AS patients
I/C
local anesthesia (LA) and general anesthesia (GA), LA vs. GA
O
30-day mortality, procedural time, new pacemaker implantation, total stay in the hospital, use of the vasoactive drug, intra-and postoperative complications and emergencies
P
patients who received LA
I/C
Phentolamine injection after LA, placebo or sham
O
return of normal sensation
P
pacientes con COVID-19
I/C
inhibidores de la enzima convertidora de angiotensina, bloqueadores del receptor de angiotensina II, placebo o ningún tratamiento
O
efectos sobre la COVID-19
P
locally advanced or metastatic urothelial carcinoma (la/mUC)
I/C
first-line (1L) treatment regimens, standard of care (SOC)
O
overall survival (OS), progression-free survival (PFS), overall response rate (ORR)
P
dairy cows
I/C
revision of French feed unit systems, control diets, milk fat depression diets
O
ingested and intestinal flows of LA and ALA, BW and milk performance
P
embarazadas con Covid-19
I/C
Covid-19, control
O
cesáreas, partos pretérmino, admisiones a la UCI neonatal
P
simulation study
I/C
fitted five random-effects GLMMs, LA, PQL, AGHQ methods
O
convergence rate, bias, mean square error, coverage probability
P
pheochromocytoma patients
I/C
laparoscopic adrenalectomy, open adrenalectomy
O
tumor size, body mass index, perioperative and recovery outcomes, complications
P
pacientes sometidos a cirugía
I/C
intervenciones con ejercicio, controlados
O
reducción de la sarcopenia